IP Library › Granted Patent US 10,150,992
Granted Patent B2
US 10,150,992 · App. 15/202,487 · Granted Dec 11, 2018

Substrates and methods useful in sequencing

Inventors: Steven M. Menchen (Fremont, CA); Guobing Xiang (Hayward, CA); Prasanna Krishnan Thwar (Los Altos, CA); Jeffrey Frediani (San Mateo, CA); Allen Wong (San Francisco, CA); Alfred Lui (Sunnyvale, CA); Lily Lu (Foster City, CA)
Assignee: LIFE TECHNOLOGIES CORPORATION
C12Q1/686C12Q1/6834C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,992
App. No.
15/202,487
Granted
Dec 11, 2018
Kind
B2
Abstract

A hydrogel network includes a hydrogel polymer having a coupling site, an oligonucleotide conjugated at a terminal end to the hydrogel polymer at the coupling site, and a functional moiety coupled between the terminal end of the oligonucleotide and the coupling site. Such a hydrogel network can be formed by a method including activating a coupling site of a substrate and binding a linker moiety coupled to a terminal end of an oligonucleotide to the activated coupling site, a functional moiety coupled between the terminal end of the oligonucleotide and the linker moiety.

Claims (17)

1. A method of forming a nucleic acid substrate, the method comprising:

activating a coupling site of a substrate;

performing ion exchange on a modified oligonucleotide comprising a linker moiety coupled to a 5′ terminal end of an oligonucleotide, a functional moiety coupled between the 5′ terminal end of the oligonucleotide and the linker moiety, wherein the functional moiety is a dye moiety or a buffering moiety, wherein the functional moiety is attached to a modified nucleotide that includes a pyrimidine base, wherein the functional moiety is attached to the 5-position of the pyrimidine base; and

binding the linker moiety of the modified oligonucleotide to the activated coupling site.

2. The method of claim 1 , wherein the dye moiety is a rhodamine moiety.

3. The method of claim 1 , wherein the dye moiety is a fluorescein moiety.

4. The method of claim 1 , wherein the buffering moiety is morpholinoalkyl, triethanolamine, N-[tris(hydroxymethyl) methyl]-2-aminoethanesulfonic acid, 3-(N-tris[hydroxymethyl]methylamino)-2-hydroxypropanesulfonic acid, N-(2-hydroxyethyl)piperazine-N-(2-ethanesulfonic acid), N-(2-acetamido)-2-aminoethanesulfonic acid, imidazole, or acetate.

5. The method of claim 1 , wherein the pyrimidine base includes thymidine or cytidine.

6. The method of claim 1 , wherein the coupling site includes a carboxyl moiety and activating includes reacting with a succinimidyl compound.

7. The method of claim 1 , wherein the coupling site includes an amine moiety.

8. The method of claim 1 , further comprising hybridizing a template nucleic acid to the oligonucleotide and extending the oligonucleotide.

9. The method of claim 8 , further comprising sequencing the extended oligonucleotide.

10. The method of claim 1 , wherein the substrate is a hydrogel network.

11. The method of claim 10 , wherein the hydrogel network comprises polyacrylamide.

12. The method of claim 1 , wherein the linker moiety comprises a hydrocarbon, an ether, or polyether group.

13. The method of claim 12 , wherein the linker moiety comprises a hydrocarbon.

14. The method of claim 1 , further comprising generating the modified-oligonucleotide using phosphoramidite modified nucleotides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2016
From: MENCHEN, STEVEN; XIANG, GUOBING; THWAR, PRASANNA; FREDIANI, JEFFREY; WONG, ALLEN; LUI, ALFRED; LU, LILY
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 039983/0118 →
Continuity (2)
Provisional Application 62189019 · Jul 6, 2015
Related Publication 20170009275A1 · Jan 12, 2017
Cited By (1)
US 12,331,356